Diarrhoea, characterized by frequent and fluid bowel movements, is managed pharmacologically to reduce intestinal motility, enhance absorption, and decrease secretion while prioritizing hydration. Therapy targets underlying causes (such as infections, inflammation, or drug-induced changes), ensuring effective symptom control and patient safety.
🔬 Pathophysiology Overview
Diarrhoea arises from disruptions in intestinal water and electrolyte transport, caused by:
⚡ Motility Disorders
- Enhanced intestinal peristalsis
- Reduced transit time
- Increased fluid passage
🔋 Secretory Imbalance
- Increased chloride secretion
- Reduced sodium absorption
- Osmotic water movement
💊 Inflammatory Causes
- Infectious agents (bacterial, viral)
- Inflammatory bowel disease
- Mucosal damage
- Motility (too fast)
- Osmotic (unabsorbed solutes)
- Secretory (excess fluid secretion)
💊 Pharmacologic Classification of Antidiarrhoeal Drugs
Antidiarrhoeal drugs are categorized based on their mechanism and role in treatment. Understanding classification guides appropriate selection:
🚫 Antimotility Agents
- Examples: Loperamide, Diphenoxylate
- Mechanism: Opioid receptor agonists in gut
- Key Point: Slow transit, increase absorption
- Avoid in: Infectious diarrhoea
🧲 Adsorbents/Protectants
- Examples: Kaolin-pectin, Bismuth
- Mechanism: Bind toxins, coat mucosa
- Key Point: Local action, not absorbed
- Caution: May interfere with other drugs
🦠 Antimicrobial Agents
- Examples: Ciprofloxacin, Metronidazole
- Mechanism: Target specific pathogens
- Key Point: Cause-specific treatment
- Requires: Confirmed/suspected infection
1. Antimotility Agents (Opioid Derivatives)
These synthetic opioid analogs act on intestinal μ-opioid receptors to slow peristalsis (intestinal wave-like contractions), increasing transit time and water/electrolyte absorption.
💊 Loperamide (Imodium®)
- Mechanism of Action: Activates presynaptic μ-opioid receptors in the myenteric plexus, inhibiting acetylcholine and prostaglandin release. This reduces motility and secretion.
- Pharmacokinetics: Poorly absorbed orally; undergoes extensive first-pass metabolism (liver processing); does not cross the blood-brain barrier (BBB), minimizing CNS effects.
- Adverse Effects: Constipation, abdominal cramps, drowsiness; risk of paralytic ileus (bowel paralysis) in overdose.
- Contraindications: Infectious (bloody) diarrhoea, pseudomembranous colitis (C. difficile infection), children under 2 years.
- Clinical Uses: Symptomatic relief of acute and chronic non-infectious diarrhoea; adjunct in inflammatory bowel disease (IBD).
- Key Advantage: Minimal CNS effects due to poor BBB penetration.
💊 Diphenoxylate + Atropine (Lomotil®)
- Mechanism: Similar to loperamide but with higher CNS penetration. Atropine is added to deter abuse (causes unpleasant anticholinergic effects if misused).
- Pharmacokinetics: Orally absorbed; converted to active metabolite, diphenoxylic acid.
- Adverse Effects: Anticholinergic effects (dry mouth, blurred vision, urinary retention), CNS depression in overdose.
- Contraindications: Infectious diarrhoea, children under 6 years, hypersensitivity to atropine.
- Clinical Uses: Moderate to severe non-infectious diarrhoea.
- Key Point: Atropine component makes it less likely to be abused.
2. Adsorbents and Protectants
These agents bind toxins, bacteria, or fluids in the gut lumen and protect the intestinal lining (mucosa).
🏺 Kaolin and Pectin
- Mechanism: Adsorb (bind) bacterial toxins and fluid, increasing stool consistency.
- Pharmacokinetics: Not absorbed; acts locally in the gut.
- Adverse Effects: Constipation; potential interference with absorption of other oral drugs (take 2 hours apart).
- Clinical Uses: Mild non-specific diarrhoea.
- Key Limitation: Nonspecific action; may bind beneficial medications.
⚫ Bismuth Subsalicylate (Pepto-Bismol®)
- Mechanism: Hydrolyzes to bismuth oxide (antimicrobial, mucosal coating) and salicylic acid (inhibits prostaglandin synthesis, reducing secretion and motility).
- Pharmacokinetics: Partially absorbed; salicylate metabolized hepatically (in liver).
- Adverse Effects: Blackened tongue/stools (harmless), constipation, tinnitus (ringing in ears) from salicylate toxicity in overdose.
- Contraindications: Salicylate hypersensitivity, children with viral infections (risk of Reye's syndrome: rare but serious liver/brain condition).
- Clinical Uses: Traveler's diarrhoea, mild diarrhoea; part of Helicobacter pylori eradication therapy.
- Key Advantage: Triple action: antimicrobial, antisecretory, and protective.
3. Antisecretory Agents
These agents reduce intestinal fluid and electrolyte secretion without significantly altering motility (movement).
🔬 Racecadotril (Hidrasec®)
- Mechanism: Prodrug converted to thiorphan, an enkephalinase inhibitor; increases endogenous enkephalins (natural gut opioids), reducing cAMP-mediated secretion.
- Pharmacokinetics: Orally active; peak effect in 1–2 hours; duration 6–8 hours.
- Adverse Effects: Mild nausea, abdominal pain, rash (rare).
- Contraindications: Hypersensitivity, severe renal impairment.
- Clinical Uses: Acute secretory diarrhoea in children and adults; adjunct to rehydration.
- Key Benefit: Reduces fluid loss without causing constipation.
💉 Octreotide (Sandostatin®)
- Mechanism: Synthetic somatostatin analog; inhibits secretion of serotonin, gastrin, and vasoactive intestinal peptide (VIP), reducing secretion and motility.
- Pharmacokinetics: Administered subcutaneously (SC) or IV; duration 8–12 hours.
- Adverse Effects: Steatorrhea (fatty stools), gallstone formation, abdominal discomfort.
- Contraindications: Hypersensitivity, biliary tract obstruction.
- Clinical Uses: Diarrhoea from carcinoid tumors, VIPomas (tumors secreting VIP), diabetic neuropathy, chemotherapy-induced diarrhoea.
- Key Point: Reserved for severe, hormone-mediated diarrhoea syndromes.
4. Antimicrobial Agents
Used for diarrhoea caused by specific bacterial or protozoal infections, guided by clinical presentation and local resistance patterns.
| Condition/Pathogen | First-line Antimicrobial | Alternative | Key Points |
|---|---|---|---|
| Traveler's Diarrhoea (often E. coli) | Azithromycin | Ciprofloxacin* | *Increasing resistance to fluoroquinolones |
| Cholera (Vibrio cholerae) | Azithromycin (single dose) | Doxycycline | Reduces duration and fluid loss |
| C. difficile Infection | Oral Vancomycin or Fidaxomicin | Metronidazole (mild cases) | AVOID antimotility agents! |
| Giardiasis (Giardia lamblia) | Metronidazole | Tinidazole (single dose) | Treat even asymptomatic carriers |
| Shigellosis | Azithromycin | Ciprofloxacin | Highly contagious; needs antibiotics |
5. Oral Rehydration Therapy (ORT)
The cornerstone of diarrhoea management. ORT promotes sodium and water absorption via the sodium-glucose cotransporter (SGLT1) in the intestine.
🧂 WHO Oral Rehydration Solution (ORS) Formula
- Glucose: 20 g/L (drives sodium absorption)
- Sodium chloride: 3.5 g/L
- Potassium chloride: 1.5 g/L
- Trisodium citrate: 2.9 g/L (or sodium bicarbonate)
- Osmolarity: 245 mOsm/L (reduced from earlier formulations)
Mechanism: Glucose enhances sodium absorption via SGLT1; water follows osmotically.
💉 When IV Rehydration is Needed
- Severe dehydration (≥10% body weight loss)
- Shock (low blood pressure, rapid heart rate)
- Altered mental status (confusion, lethargy)
- Persistent vomiting (cannot tolerate oral intake)
- Severe electrolyte disturbances
IV Solutions: Ringer's lactate or normal saline with potassium replacement.
📋 Summary Table: Drugs for Diarrhoea
| Drug/Class | Mechanism of Action | Main Use | Key Adverse Effects | Contraindications |
|---|---|---|---|---|
| Loperamide | μ-Opioid agonist; ↓ motility & secretion | Acute/chronic non-infectious diarrhoea | Constipation, abdominal cramps | Infectious diarrhoea, children <2 years |
| Bismuth subsalicylate | Antisecretory, antimicrobial, mucosal coating | Traveler's diarrhoea, mild diarrhoea | Dark stool/tongue, salicylate toxicity | Salicylate allergy, Reye's risk |
| Racecadotril | Enkephalinase inhibitor; ↓ cAMP secretion | Acute secretory diarrhoea | Nausea, rash (rare) | Hypersensitivity, severe renal impairment |
| Octreotide | Somatostatin analog; ↓ GI secretion/motility | Hormone-related diarrhoea (VIPoma, carcinoid) | Steatorrhea, gallstones | Biliary obstruction |
| ORS (Oral Rehydration Solution) | SGLT1-mediated Na⁺/glucose absorption | ALL diarrhoea (cornerstone therapy) | Rare; vomiting if too fast | Severe dehydration (needs IV) |
🎯 Clinical Decision Guide
Flowchart for diarrhoea management:
• Fever/bloody stools? → Consider infection → Stool tests
• Recent antibiotics? → Suspect C. difficile
• Travel history? → Traveler's diarrhoea
• Chronic with flushing? → Consider carcinoid/VIPoma
• All patients need hydration
• Mild-moderate: ORS
• Severe/shock: IV fluids
• Non-infectious → Loperamide
• Traveler's diarrhoea → Bismuth or Azithromycin
• Secretory (watery) → Racecadotril
• Specific infection → Targeted antibiotic
• Hormone-mediated → Octreotide
- Bloody diarrhoea with fever
- Severe abdominal pain
- Signs of dehydration (no urine >12h, dry mouth, dizziness)
- Altered mental status
- Diarrhoea in infants <6 months or elderly with comorbidities
🧠 Key Pharmacologic Principles
Essential considerations for understanding and managing diarrhoea:
⚡ Mechanism-Based Treatment
- Motility disorders → Antimotility agents
- Secretory diarrhoea → Antisecretory drugs
- Infectious causes → Antimicrobials
- ALL types → Rehydration
🔋 Safety Considerations
- Avoid antimotility drugs in infection
- Monitor electrolyte balance
- Consider drug interactions (adsorbents)
- Age-specific precautions
💊 Special Populations
- Children: ORS first, avoid certain drugs
- Elderly: Watch for dehydration
- Pregnancy: Limited drug options
- Immunocompromised: Aggressive management
- Learn mechanisms: Opioid agonists vs enkephalinase inhibitors vs adsorbents
- Know contraindications: When NOT to use each drug class
- Master ORS: Composition, mechanism, indications
- Distinguish infections: Which antibiotic for which pathogen?
- Remember brand/generic: Loperamide = Imodium, Bismuth = Pepto-Bismol
- Understand kinetics: Why loperamide has few CNS effects
🧭 Conclusion
Pharmacologic management of diarrhoea requires a tailored approach based on etiology and severity. Antimotility agents (loperamide, diphenoxylate) provide symptomatic relief for non-infectious cases but are contraindicated in infectious diarrhoea. Adsorbents like bismuth subsalicylate offer antimicrobial and protective benefits, making them valuable for traveler's diarrhoea.
Antisecretory agents target specific pathways: racecadotril for general secretory diarrhoea and octreotide for hormone-mediated conditions. Antimicrobial therapy should be reserved for confirmed or highly suspected bacterial/protozoal infections, guided by local resistance patterns.
Throughout all management, Oral Rehydration Therapy remains the cornerstone intervention. The glucose-sodium cotransport mechanism in ORS effectively restores fluid and electrolyte balance, preventing dehydration complications. Remember: Hydration saves lives; drugs provide adjunctive relief.
By understanding mechanisms, contraindications, and appropriate indications for each drug class, clinicians can optimize diarrhoea management while minimizing risks and complications.
Diarrhoea management balances symptom control with cause identification — hydration is universal, while drug selection must be etiology-specific. When in doubt, rehydrate and refer; inappropriate antidiarrhoeal use can be more harmful than the diarrhoea itself.